NCT04385277 · Interventional trial
Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
Overall registry status Active not recruiting
Phase 2
Conditions Ganglioneuroblastoma, Nodular, Neuroblastoma
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
- Saint Christopher's Hospital for Children · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory